Cambridge Investment Research Advisors, Inc. Catalent, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,831 shares of CTLT stock, worth $243,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,831
Previous 7,670
50.05%
Holding current value
$243,191
Previous $431,000
46.17%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CTLT
# of Institutions
319Shares Held
114MCall Options Held
571KPut Options Held
2.03M-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$473 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$406 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
-
Barclays PLC London, X04.28MShares$272 Million0.07% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...